NSF award 2528115 · Limax Biosciences, INC.
SBIR Phase I: Hemostatic Tough Adhesive Hydrogels for Advanced Biosurgery
Final report due
31 May 2027
in 225 days · The award ends on 31 January 2027.
GrantClerk is a private service. We are not NSF or any government agency.
Dates this award owes
NSF emails you about this too.
- Extension request17 Dec 2026in 60 days
award ending 2027-01-31 · Research.gov
- No-cost extension notice21 Jan 2027in 95 days
award ending 2027-01-31 · Research.gov
- Final report due31 May 2027in 225 days
award ending 2027-01-31 · Research.gov
- Project outcomes report due31 May 2027in 225 days
award ending 2027-01-31 · Research.gov
- Award is closed out31 May 2027in 225 days
award ending 2027-01-31 · Research.gov
Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.
How we got this date
- NSF lists this award's end date as 31 January 2027.
- NSF rules say the final report is due no later than 120 days after that.
- So the final report is due by 31 May 2027.
Get a note before each report date
Add this award to your desk. We email you before each date and keep the dates in one place.
Renews each year until you cancel. Cancel any time from your account.
Award card
- Award number
- 2528115
- Period of support
- 1 Oct 2025 – 31 Jan 2027
- Amount
- $305,000
- Awardee
- Limax Biosciences, INC., Somerville, MA
- Program
- SBIR Phase I
- Directorate
- TIP
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to address longstanding unmet needs in bleeding control. Uncontrolled bleeding is a major intraoperative issue and postoperative complication with high economic impacts, increasing procedural costs up to $30,000. Of 1.6 million surgical procedures in the US, 15% or 240,000 patients underwent re-operation due…
Is this right?
We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.